Latest News for MVPT
BOSTON, Aug. 3, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced publication of a study providing new evidence supporting the safety and efficacy of Haemonetics' VASCADE MVP ® XL venous vascular closure system in large-bore sheath procedures. The retrospective cohort study…
Napco Security Technologies is transitioning from hardware to a SaaS model, with recurring service revenue now comprising 51% of total sales at 90%+ gross margins. I assign NSSC a buy rating and a $50 per share target, citing robust operating leverage, a debt-free balance sheet, and strong free cash flow generation. The imminent MVP cloud platform launch is expected to catalyze high-margin recurring revenue growth,…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for MVPT.
Senate Trading
No Senate trades found for MVPT.
U.S. House Trading
No House trades found for MVPT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.